C-reactive protein may be increased in migraine patients who present with complex clinical features
- PMID: 16492227
- DOI: 10.1111/j.1526-4610.2006.00330.x
C-reactive protein may be increased in migraine patients who present with complex clinical features
Abstract
Objectives: Stroke risk is increased in migraine, the basis of which remains to be established. C-reactive protein (CRP) is a marker of cerebrovascular disease, suggesting in part an inflammatory mechanism. Because attacks of migraine may involve repeated sterile vascular inflammation, we measured CRP in migraine patients.
Methods: Retrospective review was conducted of 60 randomly sampled charts of patients with the diagnosis of migraine without aura (MwoA, n = 29) and migraine with aura (MwA, n = 31), in which CRP was recorded as part of the differential diagnostic evaluation. CRP was measured by standard commercial laboratory methods; high sensitivity CRP (hs-CRP) values above 3mg/L were considered abnormal.
Results: Elevated hs-CRP was found in 43% of all patients (26 of 60). In MwoA, of 29 subjects, abnormal hs-CRP was recorded in 16; in 10 no other conditions were found to explain the abnormality. In MwA, of 31 subjects, abnormal CRP was recorded in 10; in 5 no other condition could explain the abnormality. No associations were found between other demographic or clinical features.
Conclusions: CRP may be abnormal in MwoA and MwA patients who present with atypical, severe, or complex clinical features that require extensive differential diagnostic investigation.
Similar articles
-
Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease.Transl Res. 2007 Sep;150(3):158-63. doi: 10.1016/j.trsl.2007.02.006. Epub 2007 May 25. Transl Res. 2007. PMID: 17761368
-
Plasma 5-hydroxytryptamine (5-HT) in migraine during an attack-free period.Headache. 2006 Apr;46(4):592-6. doi: 10.1111/j.1526-4610.2006.00408.x. Headache. 2006. PMID: 16643553
-
High sensitivity C-reactive protein and cerebral white matter hyperintensities on magnetic resonance imaging in migraine patients.J Headache Pain. 2015;16:9. doi: 10.1186/1129-2377-16-9. Epub 2015 Jan 16. J Headache Pain. 2015. PMID: 25595197 Free PMC article.
-
[Migraine and stroke].Tidsskr Nor Laegeforen. 1998 Mar 30;118(9):1410-2. Tidsskr Nor Laegeforen. 1998. PMID: 9599507 Review. Norwegian.
-
C-reactive protein and migraine. Facts or speculations?Clin Chem Lab Med. 2014 Sep;52(9):1265-72. doi: 10.1515/cclm-2014-0011. Clin Chem Lab Med. 2014. PMID: 24717337 Review.
Cited by
-
Proteome-wide Mendelian randomization identified potential drug targets for migraine.J Headache Pain. 2024 Sep 11;25(1):148. doi: 10.1186/s10194-024-01853-9. J Headache Pain. 2024. PMID: 39261750 Free PMC article.
-
Mediators of the association between depression and migraine: a mendelian randomization study.Front Genet. 2024 May 31;15:1326817. doi: 10.3389/fgene.2024.1326817. eCollection 2024. Front Genet. 2024. PMID: 38881795 Free PMC article.
-
Altered immunity in migraine: a comprehensive scoping review.J Headache Pain. 2024 Jun 7;25(1):95. doi: 10.1186/s10194-024-01800-8. J Headache Pain. 2024. PMID: 38844851 Free PMC article. Review.
-
Exploring PGE2 and LXA4 Levels in Migraine Patients: The Potential of LXA4-Based Therapies.Diagnostics (Basel). 2024 Mar 17;14(6):635. doi: 10.3390/diagnostics14060635. Diagnostics (Basel). 2024. PMID: 38535055 Free PMC article.
-
Association between diet and migraine characteristics: The role of dietary inflammatory index.Curr J Neurol. 2020 Apr 3;19(2):67-75. doi: 10.18502/cjn.v19i2.4943. Curr J Neurol. 2020. PMID: 38011387 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous